Diffuse large B-cell lymphoma resembling a metastatic liver tumour
Transient abnormal myelopoiesis (TAM) in a neonate without Down syndrome
Wrong blood in tube – potential for serious outcomes: can it be prevented?
Recent advances and future directions in targeting the secretory apparatus in multiple myeloma
Monitoring of chimerism following allogeneic haematopoietic stem cell transplantation (HSCT): Technical recommendations for the use of Short Tandem Repeat (STR) based techniques, on behalf of the United Kingdom National External Quality Assessment Service for Leucocyte Immunophenotyping Chimerism Working Group
Otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR™ therapeutic protein, for relapsed or refractory NHL patients
Phase I-II trial of oral cyclophosphamide, prednisone and lenalidomide for the treatment of patients with relapsed and refractory multiple myeloma
Addition of bortezomib to standard dose chop chemotherapy improves response and survival in relapsed mantle cell lymphoma
Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide
Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial
Clinical characteristics and healthcare utilization of patients with multicentric Castleman disease
Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy
Genetic polymorphisms influencing total and γ′ fibrinogen levels and fibrin clot properties in Africans
Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates
Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG study
Microparticles as biomarkers of osteonecrosis of the hip in sickle cell disease
ZAP70 expression directly promotes chronic lymphocytic leukaemia cell adhesion to bone marrow stromal cells
Interleukin-22 in the diagnosis of active chronic graft-versus-host disease in paediatric patients
Expression of the inhibitory Fc gamma receptor IIB (FCGR2B, CD32B) on follicular lymphoma cells lowers the response rate to rituximab monotherapy (SAKK 35/98)
An alternative dosing strategy of lenalidomide for patients with relapsed multiple myeloma
CALR versus JAK2 mutated essential thrombocythaemia – a report on 141 patients
Accumulation of adverse prognostic markers worsens prognosis in chronic lymphocytic leukaemia
Variable phenotypes of sickle cell disease in India with the Arab-Indian haplotype